Lobit

Lobit 50/12.5mg Tablet

Hydrochlorothiazide

Winlet Pharmaceuticals (Pvt) Ltd.

Drug Identity

Active Ingredient
Hydrochlorothiazide
Drug Class
Angiotensin-Ii Antagonists, Combinations
ATC Code
C03AA03
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Hepatic impairment, anuria, moderate to severe renal impairment, dialysis, intravascular volume depletion

Important Warnings

Hepatic impairment, renal impairment, intravascular volume depletion, renal artery stenosis, obstructive valvular disease, aortic stenosis, outflow obstruction, cardiomyopathy, SLE, gout, obstructive valvular disease
Monitor serum electrolytes

Side Effects

Hyperkalaemiaangioedemasymptomatic hypotension including dizziness particularly in patients with intravascular volume depletione.g. those taking high-dose diureticsarthralgiarhinitisflatulenceorthostatic effectsdiarrhoealiver function abnormalitiesmyalgiahypertriglyceridaemiamigraineurticariapruritus

Drug Interactions

Barbiturates
narcotics
antidiabetic agents
cholestyramine
colestipol
corticosteroids
ACTH
adrenaline

Pregnancy & Lactation

Pregnancy
Contraindicated in pregnancy.
Lactation
Not recommended.

Price Intelligence

Rs 572.45
DRAP approved maximum price · per pack of 20 · approved 01 Jul, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 20Rs 572.45

Should you consider an alternative?

Other options containing Hydrochlorothiazide, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.